Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

about

Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

Item

http://www.wikidata.org/entity/Q43176747

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

@en

Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

@nl

type

Item

label

Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

@en

Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

@nl

prefLabel

Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

@en

Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

@nl

P1476

Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs.

@en

P2093

Chenlin Shen

http://www.w3.org/2001/XMLSchema#string

Faustina Pappoe

http://www.w3.org/2001/XMLSchema#string

Haiqin Tang

http://www.w3.org/2001/XMLSchema#string

Jihan Huang

http://www.w3.org/2001/XMLSchema#string

Jun Li

http://www.w3.org/2001/XMLSchema#string

Lin Li

http://www.w3.org/2001/XMLSchema#string

Ping Zhang

http://www.w3.org/2001/XMLSchema#string

Tingting Hu

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaohui Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas

Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Low-dose aspirin for the prevention of atherothrombosis

Warfarin, aspirin, or both after myocardial infarction

Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service

Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials

Combining aspirin with oral anticoagulant therapy: is this a safe and effective practice in patients with atrial fibrillation?

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

P304

530-541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00498254.2015.1096979

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26548565

http://www.w3.org/2001/XMLSchema#string